TY - JOUR
T1 - Photobiomodulation as an Adjunctive Treatment to Physiotherapy for Reduction of Anterior Knee Pain in Combat Soldiers
T2 - A Prospective, Double-Blind, Randomized, Pragmatic, Sham-Controlled Trial
AU - Gavish, Lilach
AU - Spitzer, Elad
AU - Friedman, Ilan
AU - Lowe, Joseph
AU - Folk, Nathalie
AU - Zarbiv, Yonaton
AU - Gelman, Evgeny
AU - Vishnevski, Lev
AU - Fatale, Evgeny
AU - Herman, Michael
AU - Gofshtein, Roni
AU - Gam, Arnon
AU - Gertz, S. David
AU - Eisenkraft, Arik
AU - Barzilay, Yair
N1 - Publisher Copyright:
© 2021 Wiley Periodicals LLC
PY - 2021/12
Y1 - 2021/12
N2 - Background and Objectives: Anterior knee pain (AKP) is the most common knee pathology in athletes and occurs in 15% of army recruits of elite units during basic training. Of these, 50% are symptomatic 6 years later. Photobiomodulation (PBM) is a nonthermal red-to-near-infrared irradiation used for pain reduction of a variety of etiologies. This study was designed to determine whether addition of PBM to physiotherapy (PT) for AKP in combat soldiers is superior to PT alone. Study Design/Materials and Methods: In this prospective, double-blind, sham-controlled, randomized clinical trial (NCT02845869), 26 combat soldiers/policemen (male:female, 15:11; body mass index [BMI] = 24.2 ± 3.9, n = 46 knees), with AKP due to overuse/load, received 4 weeks of PT + sham (PT + Sham) or active PBM (wavelength = 660 and 850 nm, pulsing = 2.5 Hz, LED power = 50 mW/cm2 [local tissue/regional lymph nodes]; 810 nm continuous beam, laser cluster 6 W/cm2 [analgesia] and laser pointer 4.75 W/cm2 [trigger points]) (PT + PBM). The main outcome measures were subjective pain by visual analog scale (VAS) (0 [none]–100 [intolerable]) and functional disability by Kujala score (0 [worst]–100 [best]). Evaluations were carried out at baseline, end of treatments, and 3-month follow-up. Results: All participants completed the treatment protocol without any reported adverse device effects. Post-treatment pain was significantly reduced in the PT+PBM group, compared with baseline and sham (Δpain, VAS, mean ± SD: PT + PBM = −19 ± 23, P = 0.002; PT + Sham = −6 ± 21, P = 0.16; between groups, P = 0.032). At 3-month follow-up, pain reduction was similar between groups; however, the Kujala score was significantly improved only in the PBM-treated group (ΔKujala: PT + PBM = 11 ± 10, P = 0.003; PT + Sham = 5 ± 7, P = 0.059). Conclusions: Addition of PBM to PT for AKP resulted in earlier reduction in pain and improved functionality, compared with PT alone. This noninvasive, nonpharmacologic, adjunctive therapeutic modality can be easily incorporated into team healthcare frameworks or end units and may lead to earlier return to competition or combat-level service. Lasers Surg. Med.
AB - Background and Objectives: Anterior knee pain (AKP) is the most common knee pathology in athletes and occurs in 15% of army recruits of elite units during basic training. Of these, 50% are symptomatic 6 years later. Photobiomodulation (PBM) is a nonthermal red-to-near-infrared irradiation used for pain reduction of a variety of etiologies. This study was designed to determine whether addition of PBM to physiotherapy (PT) for AKP in combat soldiers is superior to PT alone. Study Design/Materials and Methods: In this prospective, double-blind, sham-controlled, randomized clinical trial (NCT02845869), 26 combat soldiers/policemen (male:female, 15:11; body mass index [BMI] = 24.2 ± 3.9, n = 46 knees), with AKP due to overuse/load, received 4 weeks of PT + sham (PT + Sham) or active PBM (wavelength = 660 and 850 nm, pulsing = 2.5 Hz, LED power = 50 mW/cm2 [local tissue/regional lymph nodes]; 810 nm continuous beam, laser cluster 6 W/cm2 [analgesia] and laser pointer 4.75 W/cm2 [trigger points]) (PT + PBM). The main outcome measures were subjective pain by visual analog scale (VAS) (0 [none]–100 [intolerable]) and functional disability by Kujala score (0 [worst]–100 [best]). Evaluations were carried out at baseline, end of treatments, and 3-month follow-up. Results: All participants completed the treatment protocol without any reported adverse device effects. Post-treatment pain was significantly reduced in the PT+PBM group, compared with baseline and sham (Δpain, VAS, mean ± SD: PT + PBM = −19 ± 23, P = 0.002; PT + Sham = −6 ± 21, P = 0.16; between groups, P = 0.032). At 3-month follow-up, pain reduction was similar between groups; however, the Kujala score was significantly improved only in the PBM-treated group (ΔKujala: PT + PBM = 11 ± 10, P = 0.003; PT + Sham = 5 ± 7, P = 0.059). Conclusions: Addition of PBM to PT for AKP resulted in earlier reduction in pain and improved functionality, compared with PT alone. This noninvasive, nonpharmacologic, adjunctive therapeutic modality can be easily incorporated into team healthcare frameworks or end units and may lead to earlier return to competition or combat-level service. Lasers Surg. Med.
KW - anterior knee pain
KW - low-level laser
KW - patellofemoral
KW - photobiomodulation
UR - http://www.scopus.com/inward/record.url?scp=85107553895&partnerID=8YFLogxK
U2 - 10.1002/lsm.23442
DO - 10.1002/lsm.23442
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34101208
AN - SCOPUS:85107553895
SN - 0196-8092
VL - 53
SP - 1376
EP - 1385
JO - Lasers in Surgery and Medicine
JF - Lasers in Surgery and Medicine
IS - 10
ER -